1-11 of 11
Anna Norhammar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Measures of Insulin Resistance as a Screening Tool for Dysglycemia in Patients With Coronary Artery Disease: A Report From the EUROASPIRE V Population

Giulia Ferrannini, Dirk De Bacquer, Iris Erlund, Viveca Gyberg, Kornelia Kotseva, Linda Mellbin, Anna Norhammar, Oliver Schnell, Jaakko Tuomilehto, Terhi Vihervaara, David Wood, Lars Rydén
Journal: Diabetes Care
Diabetes Care 2022;45(9):2111–2117
https://doi.org/10.2337/dc22-0272
Published: 30 June 2022
View article titled, Measures of Insulin Resistance as a Screening Tool for Dysglycemia in Patients With Coronary Artery Disease: A Report From the EUROASPIRE V Population
Open the PDF for Measures of Insulin Resistance as a Screening Tool for Dysglycemia in Patients With Coronary Artery Disease: A Report From the EUROASPIRE V Population in another window
Journal Articles

Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study

Robin Kristófi, Johan Bodegard, Anna Norhammar, Marcus Thuresson, David Nathanson, Thomas Nyström, Kåre I. Birkeland, Jan W. Eriksson
Journal: Diabetes Care
Diabetes Care 2021;44(5):1211–1218
https://doi.org/10.2337/dc20-2839
Published: 02 March 2021
View article titled, Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study
Open the PDF for Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study in another window
Journal Articles

Is Coronary Artery Disease Inevitable in Type 2 Diabetes? From a Glucocentric to a Holistic View on Patient Management

Giulia Ferrannini, Anna Norhammar, Viveca Gyberg, Linda Mellbin, Lars Rydén
Journal: Diabetes Care
Diabetes Care 2020;43(9):2001–2009
https://doi.org/10.2337/dci20-0002
Published: 13 July 2020
View article titled, Is Coronary Artery Disease Inevitable in Type 2 Diabetes? From a Glucocentric to a Holistic View on Patient Management
Open the PDF for Is Coronary Artery Disease Inevitable in Type 2 Diabetes? From a Glucocentric to a Holistic View on Patient Management in another window
Journal Articles

Response to Comment on Norhammar et al. Undetected Dysglycemia Is an Important Risk Factor for Two Common Diseases, Myocardial Infarction and Periodontitis: A Report From the PAROKRANK Study. Diabetes Care 2019;42:1504–1511

Anna Norhammar, Barbro Kjellström, Natalie Habib, Anders Gustafsson, Björn Klinge, Åke Nygren, Per Näsman, Elisabet Svenungsson, Lars Rydén
Journal: Diabetes Care
Diabetes Care 2020;43(1):e9
https://doi.org/10.2337/dci19-0055
Published: 12 December 2019
View article titled, Response to Comment on Norhammar et al. Undetected Dysglycemia Is an Important Risk Factor for Two Common Diseases, Myocardial Infarction and Periodontitis: A Report From the PAROKRANK Study. Diabetes Care 2019;42:1504–1511
Open the PDF for Response to Comment on Norhammar et al. Undetected Dysglycemia Is an Important Risk Factor for Two Common Diseases, Myocardial Infarction and Periodontitis: A Report From the PAROKRANK Study. Diabetes Care 2019;42:1504–1511 in another window
Journal Articles

Undetected Dysglycemia Is an Important Risk Factor for Two Common Diseases, Myocardial Infarction and Periodontitis: A Report From the PAROKRANK Study

Anna Norhammar, Barbro Kjellström, Natalie Habib, Anders Gustafsson, Björn Klinge, Åke Nygren, Per Näsman, Elisabet Svenungsson, Lars Rydén
Journal: Diabetes Care
Diabetes Care 2019;42(8):1504–1511
https://doi.org/10.2337/dc19-0018
Published: 10 June 2019
View article titled, Undetected Dysglycemia Is an Important Risk Factor for Two Common Diseases, Myocardial Infarction and Periodontitis: A Report From the PAROKRANK Study
Open the PDF for Undetected Dysglycemia Is an Important Risk Factor for Two Common Diseases, Myocardial Infarction and Periodontitis: A Report From the PAROKRANK Study in another window
Includes: Supplementary data
Journal Articles

Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6–10

Thomas Nyström, Johan Bodegård, David Nathanson, Marcus Thuresson, Anna Norhammar, Jan W. Eriksson
Journal: Diabetes Care
Diabetes Care 2018;41(6):e104–e105
https://doi.org/10.2337/dc18-0339
Published: 11 May 2018
View article titled, Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6–10
Open the PDF for Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6–10 in another window
Journal Articles

Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6–10

Marcus Thuresson, Matthew A. Cavender, Alex Z. Fu, John P. Wilding, Kamlesh Khunti, Reinhard W. Holl, Anna Norhammar, Kåre I. Birkeland, Marit Eika Jørgensen, Eric Wittbrodt, Niklas Hammar, Peter Fenici, Mikhail Kosiborod, CVD-REAL Investigators and Study Group, Mikhail Kosiborod, Matthew A. Cavender, Alex Z. Fu, John P. Wilding, Kamlesh Khunti, Anna Norhammar, Kåre Birkeland, Marit Eika Jørgensen, Reinhard W. Holl, Niklas Hammar, Peter Fenici, Niki Arya, Kyle Nahrebne, Karolina Andersson-Sundell, Johan Bodegård, Betina T. Blak, Sara E. Dempster, Kelly Bell, Eric T. Wittbrodt, Markus F. Scheerer, Hanne Løvdal Gulseth, Bendix Carstensen, Marcus Thuresson, Esther Bollow, Luis Alberto García Rodríguez, Lucia Cea Soriano, Oscar Fernández Cantero, Ellen Riehle, Brian Murphy
Journal: Diabetes Care
Diabetes Care 2018;41(6):e106–e108
https://doi.org/10.2337/dc18-0338
Published: 11 May 2018
View article titled, Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6–10
Open the PDF for Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6–10 in another window
Includes: Supplementary data
Journal Articles

Characteristics and Prognosis in Women and Men With Type 1 Diabetes Undergoing Coronary Angiography: A Nationwide Registry Report

Viveca Ritsinger, Christel Hero, Ann-Marie Svensson, Nawzad Saleh, Bo Lagerqvist, Katarina Eeg-Olofsson, Anna Norhammar
Journal: Diabetes Care
Diabetes Care 2018;41(4):876–883
https://doi.org/10.2337/dc17-2352
Published: 20 February 2018
View article titled, Characteristics and Prognosis in Women and Men With Type 1 Diabetes Undergoing Coronary Angiography: A Nationwide Registry Report
Open the PDF for Characteristics and Prognosis in Women and Men With Type 1 Diabetes Undergoing Coronary Angiography: A Nationwide Registry Report in another window
Includes: Supplementary data
Journal Articles

Oral Glucose Tolerance Test: A Reliable Tool for Early Detection of Glucose Abnormalities in Patients With Acute Myocardial Infarction in Clinical Practice: A report on repeated oral glucose tolerance tests from the GAMI Study

Märit Wallander, MD, Klas Malmberg, MD, PHD, Anna Norhammar, MD, PHD, Lars Rydén, MD, PHD, Åke Tenerz, MD, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(1):36–38
https://doi.org/10.2337/dc07-1552
Published: 01 January 2008
View article titled, Oral Glucose Tolerance Test: A Reliable Tool for Early Detection of Glucose Abnormalities in Patients With Acute Myocardial Infarction in Clinical Practice: <subtitle>A report on repeated oral glucose tolerance tests from the GAMI Study</subtitle>
Open the PDF for Oral Glucose Tolerance Test: A Reliable Tool for Early Detection of Glucose Abnormalities in Patients With Acute Myocardial Infarction in Clinical Practice: <subtitle>A report on repeated oral glucose tolerance tests from the GAMI Study</subtitle> in another window
Journal Articles

IGF Binding Protein 1 Predicts Cardiovascular Morbidity and Mortality in Patients With Acute Myocardial Infarction and Type 2 Diabetes

Märit Wallander, MD, Anna Norhammar, MD, PHD, Klas Malmberg, MD, PHD, John Öhrvik, PHD, Lars Rydén, MD, PHD, Kerstin Brismar, MD, PHD
Journal: Diabetes Care
Diabetes Care 2007;30(9):2343–2348
https://doi.org/10.2337/dc07-0825
Published: 01 September 2007
View article titled, IGF Binding Protein 1 Predicts Cardiovascular Morbidity and Mortality in Patients With Acute Myocardial Infarction and Type 2 Diabetes
Open the PDF for IGF Binding Protein 1 Predicts Cardiovascular Morbidity and Mortality in Patients With Acute Myocardial Infarction and Type 2 Diabetes in another window
Journal Articles

Diabetes, Insulin Resistance, and the Metabolic Syndrome in Patients With Acute Myocardial Infarction Without Previously Known Diabetes

Åke Tenerz, MD, Anna Norhammar, MD, Angela Silveira, PHD, Anders Hamsten, MD, PHD, Göran Nilsson, MD, PHD, Lars Rydén, MD, PHD, Klas Malmberg, MD, PHD
Journal: Diabetes Care
Diabetes Care 2003;26(10):2770–2776
https://doi.org/10.2337/diacare.26.10.2770
Published: 01 October 2003
View article titled, Diabetes, Insulin Resistance, and the Metabolic Syndrome in Patients With Acute Myocardial Infarction Without Previously Known Diabetes
Open the PDF for Diabetes, Insulin Resistance, and the Metabolic Syndrome in Patients With Acute Myocardial Infarction Without Previously Known Diabetes in another window